Report Categories
View AllRecent Articles
View All
Can Spero Therapeutics Spro Stock Increase Dividends Price At 2.63 Down 5.40 20260410
APM Aptorum shares latest biotech pipeline progress management highlights upcoming key clinical trial milestones
First FCBC Stock Schedule 13 Modest Decline 20260427
Can XOMA XOMA stock grow further Posts 026 EPS trounces loss estimates with 2645 upside
AngioDynamics ANGO Q1 2026 Earnings EPS 002 Beats Estimates
Vermont SelfStorage Operators See Boom Amid Housing Crunch and Aging Demographics
Gold and Silver Decline as Precious Metals Face Continued Pressure
FPI Selloff Deepens Financial Stocks Bear Brunt of 26304 Crore Outflows in Early May
TC Energy TRP Rises 057 Bullish Trend Intact Above 6698 20260521
Satellite and AI Technology Deployed to Track UK Hedgehog Populations Opening New Conservation Tech Frontier
Trump Seeks Supreme Court Intervention to Halt Looming TikTok Ban
Standard Chartered Targets Higher Returns with Over 15 Job Cuts in Corporate Functions Aims for 20 Income Per Employee Boost by 2028
SpaceX Scrubs Starship Test Flight Sets New Launch Attempt for Friday
Amazon UK Director Challenges Blame on Youth Unemployment Points to Education System Gap
Fed Officials May Consider Rate Hikes if Inflation Remains Elevated Minutes Reveal
Elauwit Connection Inc ELWT Surges 563 Key Levels to Watch
Nvidia Invests Billions in Photonics to Tackle AI Efficiency Bottleneck
CDE Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally
Anthony Gordons 93 Million Barcelona Transfer A Strategic Investment in Footballs Global Market
AmeriServ Financial ASRV Slides Nearly 3 as Stock Nears Critical Support Zone
enVVeno Medical NVNO Edges Lower as Stock Holds Above Key Support
PowerFleet AIOT Surges Over 8 as Support Holds Eyes Resistance at 411
IM Cannabis Corp IMCC Surges 16 VolumeDriven Rally or Sustainable Breakout
Krispy Kreme DNUT Gains Ground A Modest Rally Amidst Technical Support
Ernexa Therapeutics ERNA Faces Sharp SellOff Testing Key Support at 1020
MakeMyTrip MMYT Faces Selling Pressure at 4674 as Resistance Holds
BHFAN Preferred Shares Dip Slightly as Yield Attractiveness Holds Steady
Xenon Pharmaceuticals XENE Holds Steady Near Resistance as Trading Volume Remains Light